Clearpoint Neuro Inc reports results for the quarter ended in September 30 - Earnings Summary
08/11/2024 04:12
* Clearpoint Neuro Inc CLPT.OQ reported a quarterly
adjusted
loss of 18 cents per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -20 cents. The mean expectation of
three analysts for the quarter was for a loss of 17 cents per
share. Wall Street expected results to range from -19 cents
to -14 cents per share.
* Revenue rose 41% to $8.12 million from a year ago;
analysts
expected $7.78 million.
* Clearpoint Neuro Inc's reported EPS for the quarter was a
loss
of 18 cents.
* The company reported a quarterly loss of $4.97 million.
* Clearpoint Neuro Inc shares had risen by 19.4% this
quarter and
gained 97.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Clearpoint Neuro
Inc is $15.00
This summary was machine generated from LSEG data November 8 at
04:12 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.17 -0.18 Missed
Jun. 30 2024 -0.20 -0.16 Beat
Mar. 31 2024 -0.19 -0.16 Beat
Dec. 31 2023 -0.20 -0.19 Beat